250 related articles for article (PubMed ID: 7829825)
1. GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.
Solimena M; Butler MH; De Camilli P
J Endocrinol Invest; 1994; 17(7):509-20. PubMed ID: 7829825
[No Abstract] [Full Text] [Related]
2. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
Solimena M; De Camilli P
Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
[TBL] [Abstract][Full Text] [Related]
3. Of stiff men and sweet mice: GAD and diabetes.
Lancet; 1991 Dec; 338(8780):1428-9. PubMed ID: 1683426
[No Abstract] [Full Text] [Related]
4. The clinical significance of an autoimmune response against glutamic acid decarboxylase.
Ellis TM; Atkinson MA
Nat Med; 1996 Feb; 2(2):148-53. PubMed ID: 8574952
[TBL] [Abstract][Full Text] [Related]
5. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
6. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
[TBL] [Abstract][Full Text] [Related]
7. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
Ferraz HB
Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
[No Abstract] [Full Text] [Related]
8. The $64000 question in diabetes continues.
Atkinson MA
Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753
[No Abstract] [Full Text] [Related]
9. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies against GAD and GAD65].
Tsujii S
Nihon Rinsho; 1998 Jan; 56 Suppl 3():190-5. PubMed ID: 9513413
[No Abstract] [Full Text] [Related]
11. GAD antibodies in stiff-person syndrome.
Chang T; Lang B
Neurology; 2004 Dec; 63(11):1999-2000. PubMed ID: 15596739
[No Abstract] [Full Text] [Related]
12. [Stiff-man syndrome from the perspective of internal medicine and immunology].
Seissler J; Scherbaum WA
Internist (Berl); 2000 May; 41(5):460-6. PubMed ID: 10867902
[No Abstract] [Full Text] [Related]
13. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
15. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a novel GABAergic cell-surface marker which may link Stiff Man's syndrome and insulin-dependent diabetes mellitus.
Dumon V; Docherty M
Biochem Soc Trans; 1993 Feb; 21(1):23S. PubMed ID: 8449302
[No Abstract] [Full Text] [Related]
17. Glutamic acid decarboxylase--gene to antigen to disease.
Lernmark A
J Intern Med; 1996 Nov; 240(5):259-77. PubMed ID: 8946809
[TBL] [Abstract][Full Text] [Related]
18. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome.
Pugliese A; Gianani R; Eisenbarth GS; De Camilli P; Solimena M
Lancet; 1994 Oct; 344(8928):1027-8. PubMed ID: 7934413
[No Abstract] [Full Text] [Related]
19. Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome.
Vincent A; Grimaldi LM; Martino G; Davenport C; Todd I
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):395-7. PubMed ID: 9120459
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for limited clonality of antibodies to glutamic acid decarboxylase (GAD) in stiff man syndrome using baculovirus expressed GAD.
Johnstone AP; Nussey SS
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):659. PubMed ID: 8201354
[No Abstract] [Full Text] [Related]
[Next] [New Search]